Laura J. Robinson

Associate

Laura Robinson focuses her practice on patent litigation representing brand name pharmaceutical manufacturers in Hatch Waxman litigations. Prior to joining Finnegan, Ms. Robinson was an associate at a large Chicago-based firm for three years, and from 2007 to 2008, she served as a law clerk to the Honorable Judge Randall R. Rader, U.S. Court of Appeals for the Federal Circuit.

Ms. Robinson has a decade of experience in basic science and the pharmaceutical industry. From 1997 to 2002, she was an associate research scientist at Bristol Myers Squibb Pharmaceutical Research Institute in Wallingford, Connecticut, where she was responsible for the design and development of high throughput screening assays, and profiling assays used to identify various drug liabilities. Ms. Robinson received several awards for this research including an Excellence Award for the development of an ultra-miniaturized (1536 well) cytotoxicity assay. In addition to her work at Bristol, Ms. Robinson was involved in investigating the phenomena of multi-drug resistance at Memorial Sloan Kettering Cancer Center, Department of Molecular Pharmacology, New York, N.Y.

Ms. Robinson also devotes time to pro bono matters, her most recent case being a victory on behalf of a disabled veteran who had his disability benefits improperly reduced.

Professional Activities

• Bar Association of the District of Columbia (Patent, Trademark & Copyright Section, Co-Chair Amicus Committee, 2009-present)
• Federal Circuit Bar Association (Co-Chair Membership Committee, 2009-present)
• Federal Circuit Historical Society (Chair Membership Committee, 2009-present)
• Patent Lawyers Club of Washington
• American Chemical Society (Chemistry and the Law Section)
• American Bar Association (Intellectual Property Law Section)
• American Intellectual Property Law Association
• The Giles S. Rich American Inn of Court
  

Select Publications

• “Analysis of Recent Proposals to Reconfigure Hatch Waxman,” Journal of Intellectual Property Law, 2003.
• “The Anticircumvention Provisions of the Digital Millennium Copyright Act,” Journal of the Patent and Trademark Office Society, 2003.
• Primary author. “Human MDR-1 Protein Over-Expression Delays the Apoptotic Cascade in Chinese Hamster Ovary Fibroblasts,” Biochemistry, 1997.
• Primary author. “Effects of Membrane Potential Versus pHi on the Cellular Retention of Doxorubicin Analyzed Via a Comparison Between Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Multidrug Resistance (MDR) Transfectants,” Biochemical Pharmacology, 1996.